Login / Signup

Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma.

Ken OgasawaraMichael DoddsTimothy MackJames LympJustine Dell'AringaJeff Smith
Published in: Clinical pharmacokinetics (2021)
NCT02631044.
Keyphrases
  • diffuse large b cell lymphoma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • hodgkin lymphoma
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • nk cells
  • aqueous solution